Sadly, Pyridoxalated Hemoglobin Polyoxyethylene Is More a Dodo Than a PHOENIX*
Authors:
- 1 January 2015
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 43 (1) , 235-236
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Multicenter, Randomized, Placebo-Controlled Phase III Study of Pyridoxalated Hemoglobin Polyoxyethylene in Distributive Shock (PHOENIX)*Critical Care Medicine, 2015
- Blood SubstitutesAnnual Review of Biomedical Engineering, 2014
- Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shockVirulence, 2013
- Pathophysiologic mechanisms in septic shockLaboratory Investigation, 2013
- Sepsis: Going to the Heart of the MatterPathobiology, 2012
- Fueling the flame: bioenergy couples metabolism and inflammationJournal of Leukocyte Biology, 2012
- Bench-to-bedside review: Sepsis - from the redox point of viewCritical Care, 2011
- Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedsideIntensive Care Medicine, 2010
- Oxygen Transport Dynamics After Resuscitation With a Conjugated Hemoglobin SolutionArchives of Surgery, 2004
- Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shockFree Radical Biology and Medicine, 2000